BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36795619)

  • 1. A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study.
    Grani G; Gentili M; Siciliano F; Albano D; Zilioli V; Morelli S; Puxeddu E; Zatelli MC; Gagliardi I; Piovesan A; Nervo A; Crocetti U; Massa M; Samà MT; Mele C; Deandrea M; Fugazzola L; Puligheddu B; Antonelli A; Rossetto R; D'Amore A; Ceresini G; Castello R; Solaroli E; Centanni M; Monti S; Magri F; Bruno R; Sparano C; Pezzullo L; Crescenzi A; Mian C; Tumino D; Repaci A; Castagna MG; Triggiani V; Porcelli T; Meringolo D; Locati L; Spiazzi G; Di Dalmazi G; Anagnostopoulos A; Leonardi S; Filetti S; Durante C
    J Clin Endocrinol Metab; 2023 Jul; 108(8):1921-1928. PubMed ID: 36795619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
    Grani G; Zatelli MC; Alfò M; Montesano T; Torlontano M; Morelli S; Deandrea M; Antonelli A; Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; Castello R; Piazza C; Rossi R; Ferraro Petrillo U; Filetti S; Durante C
    Thyroid; 2021 Feb; 31(2):264-271. PubMed ID: 32475305
    [No Abstract]   [Full Text] [Related]  

  • 3. Can Age at Diagnosis and Sex Improve the Performance of the American Thyroid Association Risk Stratification System for Prediction of Structural Persistent and Recurrent Disease in Patients With Differentiated Thyroid Carcinoma? A Multicenter Study.
    Zuhur SS; Aggul H; Çelik M; Avci U; Erol S; Kilinç F; Akbaba G; Cinar N; Tekin S; Sahin S; Bilen O; Elbuken G; Guldiken S; Kadioglu P; Bayraktaroglu T; Topcu B; Altuntas Y
    Endocr Pract; 2022 Jan; 28(1):30-35. PubMed ID: 34508902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM.
    Sapuppo G; Grasso S; Di Benedetto G; Belfiore A; Pellegriti G
    Front Endocrinol (Lausanne); 2023; 14():1128963. PubMed ID: 36992807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
    Maino F; Botte M; Dalmiglio C; Valerio L; Brilli L; Trimarchi A; Mattii E; Cartocci A; Castagna MG
    J Clin Endocrinol Metab; 2024 Feb; 109(3):722-729. PubMed ID: 37804529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prospective Implementation of the 2015 ATA Guidelines and Modified ATA Recurrence Risk Stratification System for Treatment of Differentiated Thyroid Cancer in a Canadian Tertiary Care Referral Setting.
    Wu J; Hu XY; Ghaznavi S; Kinnear S; Symonds CJ; Grundy P; Parkins VM; Sharma P; Lamb D; Khalil M; Hyrcza M; Chandarana SP; Pasieka JL; Harvey A; Warshawski J; Hart R; Deutschman M; Randall DR; Paschke R
    Thyroid; 2022 Dec; 32(12):1509-1518. PubMed ID: 36226405
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
    Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
    Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving the prediction of persistent and recurrent differentiated thyroid cancer using the American Thyroid Association 2015 risk stratification system.
    Markantes GK; Karakioulaki M; Papanikolopoulou S; Theodoropoulou A; Markou KB; Vagenakis AG; Spyridonidis T; Goulis DG; Michalaki MA
    Hormones (Athens); 2021 Dec; 20(4):761-768. PubMed ID: 34383288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Thyroid Cancer: Postoperative Classifications and Response to Initial Therapy as Prognostic Factors.
    Lazar L; Lebenthal Y; Segal K; Steinmetz A; Strenov Y; Cohen M; Yaniv I; Yackobovitch-Gavan M; Phillip M
    J Clin Endocrinol Metab; 2016 May; 101(5):1970-9. PubMed ID: 26930182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
    De Leo S; D'Elia S; Grani G; Dondi F; Bertagna F; Puxeddu E; Morelli S; Piovesan A; Nervo A; Zatelli MC; Gagliardi I; Samà MT; Aimaretti G; Crocetti U; Massa M; Deandrea M; Retta F; Pagano L; Rossi M; Solaroli E; Pezzullo L; Chiofalo MG; Pontecorvi A; Lombardi CP; Antonelli A; Patrizio A; Messuti I; Magri F; Spiazzi G; Ceresini G; Bruno R; Sparano C; Centanni M; Crescenzi A; Tallini G; Marotta V; Madeo B; Mian C; Filetti S; Durante C; Fugazzola L
    Thyroid; 2023 Nov; 33(11):1318-1326. PubMed ID: 37725571
    [No Abstract]   [Full Text] [Related]  

  • 11. Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer.
    Redlich A; Luster M; Lorenz K; Lessel L; Rohrer TR; Schmid KW; Frühwald MC; Vorwerk P; Kuhlen M
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e165-e177. PubMed ID: 34415989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence.
    Pitoia F; Jerkovich F; Urciuoli C; Schmidt A; Abelleira E; Bueno F; Cross G; Tuttle RM
    Thyroid; 2015 Nov; 25(11):1235-42. PubMed ID: 26132983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
    Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
    Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer.
    van Velsen EFS; Peeters RP; Stegenga MT; van Kemenade FJ; van Ginhoven TM; van Balkum M; Verburg FA; Visser WE
    J Clin Endocrinol Metab; 2023 May; 108(6):e267-e274. PubMed ID: 36508298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
    Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
    Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
    Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
    Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.
    Ciappuccini R; Heutte N; Lasne-Cardon A; Saguet-Rysanek V; Leroy C; Le Hénaff V; Vaur D; Babin E; Bardet S
    BMC Cancer; 2020 Aug; 20(1):765. PubMed ID: 32799836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
    Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
    Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.